J Powell - US Patent D630,836, 2011 - Google Patents US00D630836S (12) United States Design Patent ao) Patent no.: us D630,836 s Powell (45) Date of Patent: ** Jan. 18,2011 (54) STRATEGIC NERVE ANTIDOTE POUCH (75) Inventor: Joshua Powell, Canyon Lake, TX (US) (73) Assignee: J. Powell Enterprises, LLC, Canyon Lake, ... Related articles - All 3 versions
[HTML] from hematologylibrary.orgEP Bianchini, J Fazavana, V Picard… - Blood, 2011 - bloodjournal.hematologylibrary.org Heparin derivative-based therapy has evolved from unfractionated heparin (UFH) to low-molecular-weight heparins (LMWHs) and now fondaparinux, a synthetic pentasaccharide. Contrary to UFH or LMWHs, fondaparinux is not neutralized by ... Cited by 1 - Related articles - All 3 versions
I Rubinstein, G Weinberg - American Journal of Respiratory and …, 2011 - Am Thoracic Soc Administration of local anesthetics, such as during bronchoscopy, is associated infrequently with acute systemic toxicity Introduction: that, in some patients, progresses to refractory cardiovascular collapse and death. Unfortunately, no antidote(s) is presently available to reverse acute ...
G Cave… - Critical care medicine, 2011 - journals.lww.com “Lipid rescue,” the use of intravenous lipid emulsion (ILE) as an antidote in lipophilic drug cardiotoxicity, has developed rapidly over the last decade. Initial animal studies and further work with local anesthetics came predominantly from the laboratory of Guy Weinberg, MD. ... Related articles - All 3 versions
S Bern, S Akpa, I Kuo… - Current Pharmaceutical …, 2011 - ingentaconnect.com Abstract: Local anesthetic toxicity is a rare, but potentially lethal, complication of regional anesthesia that cannot be pre- vented by any single measure. It is associated with CNS excitation and can lead to refractory cardiac dysfunction and col- lapse. The development of lipid emulsion ... Cited by 1 - Related articles - All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
